Izindaba

I-RD13-02 iwumkhiqizo wamaseli e-CAR-T ojwayelekile ohlose i-CD7 etholakala kubanikeli abanempilo, futhi ihloselwe ukwelapha i-T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) ephinde yatholakala noma engaphikiswa. Ishintshwe ngofuzo ukuze igweme i-fratricide, isifo se-graft-versus-host (GvHD), kanye ne-host-versus-...Funda kabanzi»

I-CT011 iwumkhiqizo we-GPC3 CAR T-cell ozimele ofanele ukwelashwa kwe-hepatocellular carcinoma (HCC). I-CT011 yathola imvume ye-IND evela kwi-NMPA ngo-2019 yokwelapha iziguli ezine-GPC3-positive solid tumor okwakuyimvume yokuqala ye-IND eShayina yokwelashwa kwe-CAR T-cell ngokumelene ne-solid ...Funda kabanzi»

Uprofesa waseyunivesithi yaseRussia oseminyakeni yakhe yokugcina yama-70 unesifo esithuthukile se-multiple myeloma. Ngemva kokwelashwa kaningi kanye nokufakelwa kabusha kwe-autologous kabili, wafunda ngokwelashwa okuphambili okulwa nomdlavuza i-CAR-T eShayina, ngakho weza eShayina ukuzokwamukela iseli le-CAR-T...Funda kabanzi»

Ngomhlaka-20 kuJulayi, i-New Drug Application (NDA) ye-pCAR-19B eyathuthukiswa ngokuzimela yi-Precision Biology yamukelwa ngokusemthethweni yi-China National Medical Products Administration (NMPA). Lo mkhiqizo uwumkhiqizo wokuqala we-CAR-T we-leukemia yezingane eShayina, osetshenziselwa ukwelapha iziguli ezineminyaka engu-3-21 ...Funda kabanzi»

I-satricabtagene autoleucel (Satri-cel, CT041) iwumkhiqizo we-CAR T-cell owukhethekayo ngokumelene nephrotheni i-Claudin18.2 enamandla okuba phambili emhlabeni jikelele. I-Satri-cel ihlasela amathumba aqinile e-Claudin18.2 ngokugxila kakhulu kumdlavuza wesisu/umdlavuza we-gastroesophageal junction...Funda kabanzi»

NgoSepthemba 6, 2021, i-JW Therapeutics yamemezela ukuthi i-National Medical Products Administration (NMPA) yaseShayina ivumile i-New Drug Application (NDA) yomkhiqizo wayo we-anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy injection (relma-cel) ...Funda kabanzi»

I-Equecabtagene autoleucel (eque-cel), ukwelashwa kwe-T-cell okuqondiswe ku-B-cell maturation-targeting chimeric antigen receptor (CAR) okususelwa kumuntu ngokugcwele, kubonise amandla okwelapha i-repeated noma i-refractory multiple myeloma (R/RMM). Ngomhlaka-30 Juni 2023, i-National Medical Products Admi...Funda kabanzi»

Ngomhlaka-11 Okthoba 2024, i-National Medical Product Administration (NMPA) yaseShayina ivumile isicelo se-Investigational New Drug (IND) se-Inaticabtagene Autoleucel (CNCT19 Injection), ukwelashwa kweseli le-antigen receptor (CAR)-T eliqondiswe ku-CD19, ukwelapha i-Immune thrombocytopenia ...Funda kabanzi»

Ngomhlaka-1 Mashi 2024, i-China National Medical Products Administration (NMPA) yavuma ukwethulwa komkhiqizo weseli ye-CAR-T i-Zevorcabtagene AutoLeucel (Zevor-cel, CT053) yokwelapha iziguli ezindala ezine-myeloma ephindaphindayo noma engaphili kahle esezithuthuke ngemuva kwemigqa emithathu yokwelashwa (...Funda kabanzi»

I-Clustered regularly interspaced short palindromic repeats (CRISPR) iyindlela yokuhlela i-genome yesizukulwane sesithathu eguqule umhlaba ngemiphumela yayo ephezulu. Isetshenziswe ukwelapha izifo ezahlukahlukene zebhayoloji kanye nokutheleleka. Amabhaktheriya ahlukahlukene...Funda kabanzi»

Icala 1: Isiguli sesilisa esineminyaka engu-69 ubudala siye esibhedlela ukuyohlolwa ngenxa yobuhlungu besifuba. Ngeshwa, sahlushwa yi-squamous cell carcinoma ephansi yephaphu eliphezulu kwesokudla. Isiguli sasingakwazi ukubekezelela ukuhlinzwa. Ngemva kokubonisana nochwepheshe, i-cryoablation yayiyisisombululo esingcono kakhulu...Funda kabanzi»

Ukuqothulwa: “Izindaba ezinhle” zeziguli ezinezimila eziqinile ezingxenyeni ezahlukene zomzimba Inkanyezi yamafilimu edumile yaseHong Kong uWu MengDa ushone ngenxa yomdlavuza wesibindi, ukuhamba kukaMalume Da kubangele abantu abaningi ukuba bazisole. “Umdlavuza wesibindi” wake waziwa njengenkosi yomdlavuza, kanti u-70% wesibindi ...Funda kabanzi»